| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 Jan 2026 | 21 Jan 2026 |
| Quarterly Results Acutaas Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve Unaudited Standalone & Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2025 as per details attached. The Board of Directors of the Company at their meeting held on Wednesday, January 28, 2026, inter alia, considered & approved Unaudited Standalone & Consolidated Financial Results of the Company for the third quarter & nine months ended December 31, 2025 (As Per BSE Announcement Dated on: 28/01/2026) The Machine Readable/legible copy of the financial results for the quarter and nine months ended December 31, 2025 is being submitted. (As Per BSE Announcement Dated on:30.01.2026) | ||
| Board Meeting | 17 Oct 2025 | 10 Oct 2025 |
| Acutaas Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended September 30 2025 as per details attached. The Board of Directors of the Company at their meeting held on Friday, October 17, 2025, inter alia, considered & approved Unaudited Standalone & Consolidated Financial Results of the Company for the second quarter & half year ended September 30, 2025. Unaudited financial results for the quarter and half year ended September 30, 2025 is enclosed. (As Per BSE Announcement Dated on:17.10.2025) | ||
| Board Meeting | 25 Sep 2025 | 25 Sep 2025 |
| Board approved the allotment of 2200 equity shares of face value of Rs. 5/- each to the eligible employee of the Company as per details attached. | ||
| Board Meeting | 29 Aug 2025 | 29 Aug 2025 |
| Intimation under Regulation 30 of SEBI(LODR) Regulations, 2015 as attached. | ||
| Board Meeting | 30 Jul 2025 | 24 Jul 2025 |
| Acutaas Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 inter alia to consider and approve Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30 2025 The Board of Directors of the Company at their meeting held on Wednesday, July 30, 2025, inter alia, considered & approved Unaudited Standalone & Consolidated Financial Results of the Company for the first quarter ended June 30, 2025 The Board of Directors at its meeting held on July 30, 2025, inter alia, approved the Unaudited Standalone and Consolidated Financial results of the Company for the quarter ended on June 30, 2025 as attached herewith. (As Per BSE Announcement Dated on :30.07.2025) | ||
| Board Meeting | 10 Jun 2025 | 10 Jun 2025 |
| Intimation under Reg 30 of SEBI (LODR) Regulations, 2015 is attached. | ||
| Board Meeting | 2 May 2025 | 24 Apr 2025 |
| Ami Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2025 inter alia to consider and approve Board Meeting Intimation for Approval Of the Audited Financial Results for the Fourth Quarter & Year ended March 31 2025 to be held on May 2 2025 and recommendation of final dividend as per details enclosed. The Board of Directors of the Company at their meeting held on Friday , May 2, 2025, inter alia, considered & approved Audited Standalone & Consolidated Financial Results of the Company for the fourth quarter & year ended March 31, 2025. (As Per Bse Announcement Dated on :02.05.2025) | ||
| Board Meeting | 16 Apr 2025 | 16 Apr 2025 |
| Board of Directors of the Company approved the change of name of the Company from Ami Organics Limited to Acutaas Chemicals Limited, subject to the approval of shareholders and other statutory authorities. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
